Results from a Randomized Study of REVLIMID® (Lenalidomide) and Rituximab (R2 …EON: Enhanced Online News (press release)BOUDRY, Switzerland–(EON: Enhanced Online News)–Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG)…
Results from a Randomized Study of REVLIMID(R) (Lenalidomide) and Rituximab (R …MarketWatch (press release)Celgene International Sarl, a subsidiary of Celgene Corporation (NASDAQ:CELG) , today announced results from a randomized study comparing REVLI…
UCB to showcase broad immunology portfolio at EULAR 2012MarketWatch (press release)Formal drug interaction studies have not been performed with rituximab or natalizumab; however because of the nature of the adverse events seen with these combinations w…
Can next-generation antibodies offset biosimilar competition?Nature.comPfizer, more recently, has joined Teva, Novartis, Merck & Co. and others in disclosing that it is testing a biosimilar version of Roche's blockbuster anti-CD20 mAb rituximab…
Spectrum Pharmaceuticals Highlights Seven Abstracts of Clinical Data at the …MarketWatch (press release)The ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on t…
Cell Therapeutics' Pixuvri® Phase 3 Clinical Trial Results Published in The …Equities.comThe EMA's Committee for Medicinal Products for Human Use ("CHMP") has accepted PIX306, CTI's ongoing randomized controlled phase 3 clinica…
Cell Therapeutics' Pixuvri® Phase 3 Clinical Trial Results Published in The …MarketWatch (press release)The EMA's Committee for Medicinal Products for Human Use ("CHMP") has accepted PIX306, CTI's ongoing randomized controlled …
'MabThera Confirmed As Beneficial For Treating Non-Hodgkin's Lymphoma'Medical News TodayThe European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded, after conducting a quality review of the geneti…
Mª Jose Aguilera y Mª Paz Giambastiani, en la jornada. | Sergio Enriquez-NistalEl Mundo.es"Así como muchos otros que actualmente están en investigación", como añadía por su parte Xavier Montalbán, director del Centro de Esclerosis Mú…
In-PharmaTechnologist.comEMA confirms Roche's MabThera made at Vacaville site poses no health riskThe Pharma LetterThe review of MabThera was initiated after the unexpected detection of Leptospira licerasiae at an early stage (pre-harvest) of the m…